"The fantastic growth of the biotechnology industry across Asia has received a great deal of attention. Of special note are the financial dynamics, sources of capital, trends and implications for the countries separately and the continent as a whole. While many sources of capital have originated with national and local government initiatives, international and domestic private capital are playing a growing role as investors gain confidence in the movement toward harmonized regulatory affairs, stronger intellectual property rights, more sophisticated partnering
alliances with off-shore companies, the establishment of research facilities by Western companies and, most important, the growing sophistication of entrepreneurial talent."

Objective1:Focus on Japan, China, India and Malaysia individually.

Objective2:Provide summary presentation on the collective implications.

Objective3:Explore issues such as sources and trends in private capital, strategic implications of comparative advantages, the evolving relationships between entrepreneurs and venture capitalists, exit mechanisms and impact on the industry globally.